Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
This article was originally published in PharmAsia News
Executive Summary
The opportunities for clinical trials in China and India are well known to the pharmaceutical industry at this point, but Edward Ian, senior director of clinical operations for PRA International-Asia Pacific, wants company leaders to take notice and advantage of the potential in other countries in Asia Pacific
You may also be interested in...
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
PharmAsia News' Top Industry Trends Of 2009
As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010
As Korea Steps Up Drive To Attract Global Clinical Trials, American CRO Opens Outpost In Seoul
SEOUL - PRA International, a clinical research organization headquartered in Raleigh, N.C., recently opened its first office in Seoul as part of an expansion across Asia